Grufity logoGrufity logo
ScreenerStocksFundsSectorsWatchlists
ELV

Elevance Health, Inc.

ELV

477.13USD+0.17 (+0.04%)Delayed as of 08 Dec 2023, 03:23 pm
Watchlist

Market Summary

USD477.13+0.17
Delayedas of 08 Dec 2023, 03:23 pm
0.04%

ELV Alerts

  • 1 major insider sales recently.

ELV Stock Price

View Fullscreen

ELV RSI Chart

ELV Valuation

Market Cap

112.0B

Price/Earnings (Trailing)

18.61

Price/Sales (Trailing)

0.66

EV/EBITDA

9.58

Price/Free Cashflow

13.59

ELV Price/Sales (Trailing)

ELV Profitability

Free Cashflow Yield

7.36%

ELV Fundamentals

ELV Revenue

Revenue (TTM)

168.6B

Revenue Y/Y

7.29%

Revenue Q/Q

-1.88%

ELV Earnings

Earnings (TTM)

6.0B

Earnings Y/Y

-19.59%

Earnings Q/Q

-30.55%

Price Action

52 Week Range

412.00498.40
(Low)(High)

Last 7 days

-0.5%

Last 30 days

4.3%

Last 90 days

6.3%

Trailing 12 Months

-5.0%

How does ELV drawdown profile look like?

ELV Financial Health

ELV Investor Care

Dividend Yield

1.2%

Dividend/Share (TTM)

5.72

Buy Backs (1Y)

1.70%

Diluted EPS (TTM)

25.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023160.7B165.7B168.6B0
2022144.3B149.1B153.2B156.6B
2021124.6B129.2B133.9B138.6B
2020109.2B113.0B117.5B121.9B
201994.2B96.8B100.2B104.2B
201890.1B90.6B91.4B92.1B
201787.1B88.1B89.1B90.0B
201680.4B81.8B83.3B84.9B
201575.1B76.6B78.0B79.2B
201471.3B72.1B72.8B73.9B
201363.7B66.0B68.6B71.0B
201261.2B61.5B61.4B61.5B
201158.5B59.2B60.0B60.7B
201065.0B64.0B63.1B58.7B
200960.8B60.6B61.1B65.0B
200861.2B61.2B61.2B61.3B
200700061.2B

Latest Insider Trading transactions for ELV

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Dec 01, 2023
todt blair williams
sold (taxes)
-56,041
483
-116
evp, clo & cao
Nov 30, 2023
penczek ronald w
sold
-501,304
475
-1,055
cao & controller
Nov 01, 2023
kendrick charles morgan jr
sold (taxes)
-35,286
446
-79.00
evp & president, commercial
Nov 01, 2023
haytaian peter d
sold (taxes)
-68,785
446
-154
evp & pres carelon & carelonrx
Oct 24, 2023
penczek ronald w
sold
-29,078
454
-64.00
cao & controller
Oct 02, 2023
kaye mark
acquired
-
-
20,276
evp & cfo designate
Jul 21, 2023
dixon robert l jr
sold
-147,780
476
-310
-
May 10, 2023
dixon robert l jr
acquired
-
-
457
-
May 10, 2023
clark r kerry
acquired
-
-
457
-
May 10, 2023
hay lewis iii
acquired
-
-
457
-

1–10 of 49

Which funds bought or sold ELV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Dec 06, 2023
Raleigh Capital Management Inc.
added
2.74
2,060
293,358
0.16%
Dec 06, 2023
CITIGROUP INC
reduced
-8.94
-11,705,300
97,122,200
0.07%
Dec 04, 2023
TUCKER ASSET MANAGEMENT LLC
new
-
1,910
1,910
-%
Dec 04, 2023
TUCKER ASSET MANAGEMENT LLC
new
-
943
943
-%
Dec 01, 2023
PFS Partners, LLC
unchanged
-
-185
10,923
0.01%
Dec 01, 2023
B. Riley Wealth Advisors, Inc.
reduced
-70.71
-3,087,420
1,243,310
0.03%
Dec 01, 2023
Fortis Group Advisors, LLC
new
-
5,660
5,660
-%
Nov 30, 2023
Scarborough Advisors, LLC
sold off
-100
-203,929
-
-%
Nov 30, 2023
Modera Wealth Management, LLC
added
2.00
-3,266
9,741,350
0.18%
Nov 30, 2023
Neo Ivy Capital Management
sold off
-100
-2,848,000
-
-%

1–10 of 45

Latest Funds Activity

Are funds buying ELV calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ELV
No. of Funds

Schedule 13G FIlings of Elevance Health, Inc.

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
price t rowe associates inc /md/
5.3%
12,717,041
SC 13G
Feb 09, 2023
vanguard group inc
8.99%
21,473,444
SC 13G/A
Jan 27, 2023
blackrock inc.
9.0%
21,566,516
SC 13G/A
Jan 25, 2023
blackrock inc.
9.0%
21,566,516
SC 13G/A

Recent SEC filings of Elevance Health, Inc.

View All Filings
Date Filed Form Type Document
Dec 05, 2023
4
Insider Trading
Dec 01, 2023
4
Insider Trading
Nov 30, 2023
144
Notice of Insider Sale Intent
Nov 03, 2023
4
Insider Trading
Nov 03, 2023
4
Insider Trading
Nov 01, 2023
S-3ASR
S-3ASR
Oct 26, 2023
4
Insider Trading
Oct 18, 2023
8-K
Current Report
Oct 18, 2023
10-Q
Quarterly Report
Oct 13, 2023
8-K
Current Report

Elevance Health, Inc. News

Latest updates
Nasdaq08 Dec 202307:00 pm94 minutes ago
MarketBeat08 Dec 202302:21 pm6 hours ago
Nasdaq07 Dec 202304:16 pm28 hours ago
MarketBeat07 Dec 202302:47 pm29 hours ago
DirectorsTalk Interviews07 Dec 202301:23 pm31 hours ago
Yahoo Finance07 Dec 202312:00 pm32 hours ago
Insider Monkey05 Dec 202304:16 pm3 days ago
Nasdaq04 Dec 202303:00 pm4 days ago
Nasdaq01 Dec 202303:59 pm7 days ago
MarketBeat30 Nov 202309:45 pm7 days ago
Nasdaq29 Nov 202312:22 pm9 days ago
Nasdaq29 Nov 202311:20 am9 days ago
Morningstar29 Nov 202308:00 am9 days ago
Nasdaq27 Nov 202308:00 am11 days ago

Financials for Elevance Health, Inc.

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Revenue-1.9%42,84943,67242,17239,92939,93938,63238,09536,58135,82233,85132,38531,82431,15829,26429,62127,40726,67425,46624,66623,37323,251
  S&GA Expenses13.5%5,4704,8184,8004,5674,5164,2724,3454,2263,9463,8213,9254,3185,3054,0463,7813,5023,4183,2783,1663,6183,546
Interest Expenses-0.8%259261251229213208201200201205192191198201194190185184187189188
Income Taxes-39.5%35458561516852948852729149455250960.00167873566164306314394118282
Earnings Before Taxes-32.2%1,6542,4412,6191,0452,1272,1222,3061,4701,9962,3532,1766113893,1492,0891,0981,4891,4531,9455421,242
Net Income-30.5%1,2891,8562,0048721,6031,6341,7791,1861,5091,8011,6675512222,2761,5239341,1831,1391,551424960
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Assets1.2%110,478109,168109,040102,755103,026100,877100,48697,45698,06096,09795,68386,61586,57487,97682,39977,45377,80975,85174,52371,57174,445
  Current Assets2.4%61,18559,74359,82355,61755,60353,65553,89751,12251,90450,23854,49545,75145,45046,76441,25639,03339,50437,80536,61134,32137,108
    Cash Equivalents9.3%10,9199,99110,1427,3878,8726,4566,1614,8805,4905,2589,3265,7413,9846,0285,3454,9374,1904,0784,4823,9344,260
  Net PPE-6.6%4,2484,5474,4184,3164,1974,0903,9863,9193,8353,7333,5333,4833,3633,4273,3503,1332,9212,8372,7992,7352,592
  Goodwill0.1%25,29125,27425,27324,38324,38124,36724,25124,22824,18424,39921,70821,69121,68721,64121,66120,50020,50020,50020,50020,50420,468
Liabilities1.5%71,93970,85671,58066,42566,98365,01064,45561,29362,25261,05161,76553,41652,65353,52150,70645,72546,47745,05844,52543,03045,351
  Current Liabilities4.2%43,33741,57141,88939,69641,28739,30839,73334,88535,16233,79434,74929,45328,56128,52227,03923,53223,23423,09022,68221,96524,174
  Short Term Borrowings-100.0%-265265265265175275275175175--150-1,0757007101,0101,0951,1451,270
    LT Debt, Current-799--1,5002,2492,2483,0971,5998498497007001,5991,6031,6031,598700850851849849
    LT Debt, Non Current-3.3%24,04524,85925,20122,34921,25821,16519,88321,15721,76122,21722,53419,33519,09419,87319,00517,78718,82017,43617,39617,21717,300
Shareholder's Equity0.3%38,42338,31237,46036,24336,05535,88736,05936,09535,80835,04633,91833,18733,92134,45531,69331,69331,33230,79329,99828,56729,094
  Retained Earnings1.6%32,10331,60830,70729,64729,60428,82528,05827,14226,70025,87424,79323,80224,67825,34623,36022,57322,10421,67921,13619,98820,182
  Additional Paid-In Capital0.8%8,8308,7618,6979,0849,1699,1349,1519,1489,1389,1099,2539,2449,3529,3609,3389,4489,5249,4949,4829,5369,720
Shares Outstanding-0.4%235236237238239240241242243244245245249252252253254256257257259
Minority Interest8.4%11610710487.0052.0055.0056.0068.0071.0078.0065.00----------
Cashflow (Last 12 Months)
(In Millions)
Cashflow (Quarterly)
(In Millions)
Description(%) Q/Q2023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q12018Q42018Q3
Cashflow From Operations34.0%2,6131,9506,469-1,5184,9242,4522,5411,6722,5041,6832,5053,813-1,1505,5102,5151,3271,6671,4371,630463607
  Share Based Compensation0%78.0078.0061.0073.0069.0072.0050.0059.0063.0069.0064.0069.0080.0067.0067.0068.0086.0070.0070.0091.0057.00
Cashflow From Investing-2.2%-687-672-3,184289-1,247-2,024-1,578-966-1,440-4,925-2,30730589.00-4,934-2,784723-1,698-1,165-652773-688
Cashflow From Financing30.5%-994-1,430-531-258-1,255-127322-1,315-830-8203,388-2,367-984105679-1,304144-677-429-1,561-340
  Dividend Payments-0.6%348350351305306309309273276278277234238242240202204206206193195
  Buy Backs-25.6%4856526225685796245455224514804471,35875855.00529305644458294493397

ELV Income Statement

2023-09-30
10-Q Consolidated Statements Of Income - USD ($)
$ in Millions
3 Months Ended9 Months Ended12 Months Ended
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Revenues           
Premiums$ 35,259  $ 33,722  $ 107,716$ 99,583$ 133,229$ 117,373$ 104,109
Product revenue5,177  3,972  14,05810,84114,97812,65710,384
Service fees2,044  1,931  5,9815,5697,4536,9136,315
Total operating revenue42,480  39,625  127,755115,993155,660136,943120,808
Net investment income493  371  1,2961,1121,4851,378877
Net losses on financial instruments(124)  (57)  (358)(439)(550)318182
Total revenues42,849  39,939  128,693116,666156,595138,639121,867
Expenses           
Benefit expense30,606$ 31,604$ 30,78629,421$ 28,795$ 28,23192,99686,447116,642102,57188,045
Cost of products sold4,648  3,437  12,4569,38913,03510,8958,953
Operating expense5,470  4,516  15,08813,13317,70015,91817,450
Interest expense259  213  771622851798784
Amortization of other intangible assets212  225  668520767441361
Total expenses41,195  37,812  121,979110,111148,995130,644115,629
Income before income tax expense1,654  2,127  6,7146,5557,6007,9956,238
Income tax expense354  529  1,5541,5441,7121,8461,666
Net income1,300$ 1,856$ 2,0041,598$ 1,634$ 1,7795,1605,0115,8886,1494,572
Net (income) loss attributable to noncontrolling interests(11)  5  (29)18690
Shareholders’ net income$ 1,289  $ 1,603  $ 5,131$ 5,029$ 5,894$ 6,158$ 4,572
Shareholders’ net income per share           
Basic net income per share$ 5.48  $ 6.69  $ 21.70$ 20.91$ 24.56$ 25.26$ 18.23
Diluted net income per share5.45  6.62  21.5620.6724.2824.9517.98
Dividends per share$ 1.48  $ 1.28  $ 4.44$ 3.84$ 5.12$ 4.52$ 3.80

ELV Balance Sheet

2023-09-30
10-Q Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Current assets:          
Cash and cash equivalents$ 10,919  $ 7,387   $ 4,880  
Fixed maturities, current27,811  25,952   26,267  
Equity securities165  953   1,881  
Premium receivables7,883  7,083   5,681  
Self-funded receivables3,756  4,663   4,010  
Other receivables5,293  4,298   3,749  
Other current assets5,358  5,281   4,654  
Total current assets61,185  55,617   51,122  
Long-term investments:          
Fixed maturities, long-term816  752   632  
Other invested assets6,118  5,685   5,225  
Property and equipment, net4,248  4,316   3,919  
Goodwill25,291  24,383   24,228$ 21,691 
Other intangible assets10,491  10,315   10,615  
Other noncurrent assets2,329  1,687   1,715  
Total assets110,478  102,755   97,456  
Current Liabilities:          
Medical claims payable16,176  15,596   13,518  
Other policyholder liabilities5,681  5,933   5,521  
Unearned income4,332  1,112   1,153  
Accounts payable and accrued expenses5,983  5,607   4,970  
Short-term borrowings0  265   275  
Current portion of long-term debt799  1,500   1,599  
Other current liabilities10,366  9,683   7,849  
Total current liabilities43,337  39,696   34,885  
Long-term debt, less current portion24,045  22,349   21,157  
Reserves for future policy benefits, noncurrent807  803   753  
Deferred tax liabilities, net1,779  2,015   2,815  
Other noncurrent liabilities1,971  1,562   1,683  
Total liabilities71,939  66,425   61,293  
Commitments and contingencies – Note 11       
Preferred stock, shares issued0  0   0  
Preferred stock, shares outstanding0  0   0  
Shareholders' equity          
Preferred stock, without par value, shares authorized – 100,000,000; shares issued and outstanding – none$ 0  $ 0   $ 0  
Common stock, par value $0.01, shares authorized – 900,000,000; shares issued and outstanding – 234,906,987 and 237,958,0672  2   2  
Additional paid-in capital8,830  9,084   9,148  
Retained earnings32,103  29,647   27,142  
Accumulated other comprehensive loss(2,512)$ (2,166) (2,490)$ (2,779)$ (2,151) (197)150$ (296)
Total shareholders' equity38,423  36,243$ 36,055  36,095  
Noncontrolling interests116  87   68  
Total equity38,539$ 38,312$ 37,46036,330 $ 35,887$ 36,05936,163$ 33,187$ 31,693
Total liabilities and shareholders' equity$ 110,478  $ 102,755   $ 97,456  
ELV
Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.
 CEO
 WEBSITEwww.elevancehealth.com
 EMPLOYEES65535

Elevance Health, Inc. Frequently Asked Questions


What is the ticker symbol for Elevance Health, Inc.? What does ELV stand for in stocks?

ELV is the stock ticker symbol of Elevance Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Elevance Health, Inc. (ELV)?

As of Thu Dec 07 2023, market cap of Elevance Health, Inc. is 112.02 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of ELV stock?

You can check ELV's fair value in chart. The fair value of Elevance Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Elevance Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for ELV so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Elevance Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether ELV is over valued or under valued. Whether Elevance Health, Inc. is cheap or expensive depends on the assumptions which impact Elevance Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for ELV.

What is Elevance Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Dec 07 2023, ELV's PE ratio (Price to Earnings) is 18.61 and Price to Sales (PS) ratio is 0.66. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. ELV PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Elevance Health, Inc.'s stock?

In the past 10 years, Elevance Health, Inc. has provided 0.194 (multiply by 100 for percentage) rate of return.